Pierre Bischoff
- Oncology top 10%
- Cancer-related Molecular Pathways 4
- PARP inhibition in cancer therapy 4
- Organic Chemistry top 10%
- Toxicology top 10%
-
- DNA Repair Mechanisms 3
- Cell death mechanisms and regulation 3
- CRISPR and Genetic Engineering 3
-
- Autophagy in Disease and Therapy 6
-
- Radiation Therapy and Dosimetry 5
-
- Cholesterol and Lipid Metabolism 4
- Co-authors
- Francis J. DumontVincent HollJean‐Pierre BergeratP. DufourJohn GueuletteJean‐Philippe LoefflerChristian GaiddonMichel Pfeffer
- Journals
- Journal of the American College of Cardiology (1 paper)Cancer Research (1 paper)Biochemical Journal (1 paper)
- Partner nations
- FranceBelgiumUnited States
In The Last Decade
Pierre Bischoff
39 papers receiving 987 citations
Peers
Comparison fields: 5 of 106
- Oncology 336
- Cancer Research 122
- Organic Chemistry 220
- Toxicology 24
- Molecular Biology 455
Countries citing papers authored by Pierre Bischoff
This map shows the geographic impact of Pierre Bischoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Bischoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Bischoff more than expected).
Fields of papers citing papers by Pierre Bischoff
This network shows the impact of papers produced by Pierre Bischoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Bischoff. The network helps show where Pierre Bischoff may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Pierre Bischoff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 6 | |
| 2 | 2012 | 26 | |
| 3 | 2012 | 27 | |
| 4 | 2012 | 14 | |
| 5 | 2009 | 190 | |
| 6 | 2009 | 19 | |
| 7 | 2009 | 62 | |
| 8 | 2008 | 27 | |
| 9 | 2007 | 7 | |
| 10 | 2006 | 10 | |
| 11 | 2005 | 5 | |
| 12 | 2004 | 9 | |
| 13 | 2004 | 12 | |
| 14 | 2003 | 113 | |
| 15 | 2003 | 36 | |
| 16 | 2000 | 19 | |
| 17 | 2000 | 25 | |
| 18 | 1993 | 59 | |
| 19 | 1989 | 20 | |
| 20 | 1989 | 3 |
About Pierre Bischoff
Pierre Bischoff is a scholar working on Toxicology, Geriatrics and Gerontology and Oncology, having authored 39 papers that have together received 1.0k indexed citations. Recurring topics across this work include Autophagy in Disease and Therapy (6 papers), Radiation Therapy and Dosimetry (5 papers), Cholesterol and Lipid Metabolism (4 papers), Cancer-related Molecular Pathways (4 papers), PARP inhibition in cancer therapy (4 papers), DNA Repair Mechanisms (3 papers), Cell death mechanisms and regulation (3 papers) and CRISPR and Genetic Engineering (3 papers). The work is most often cited by research in Oncology (336 citations), Cancer Research (122 citations) and Organic Chemistry (220 citations). Pierre Bischoff has collaborated with scholars based in France, Belgium and United States. Frequent co-authors include Francis J. Dumont, Vincent Holl, Jean‐Pierre Bergerat, P. Dufour, John Gueulette, Jean‐Philippe Loeffler, Christian Gaiddon, Michel Pfeffer, Claude B. Sirlin and Jean‐Marc Denis. Their work appears in journals such as Journal of the American College of Cardiology, Cancer Research and Biochemical Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.